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Abstract: PURPOSE The aim of this study was to differentiate malignant and benign solid breast lesions
with a novel ultrasound (US) technique, which measures speed of sound (SoS) using standard US trans-
ducers and intrinsic tissue reflections and scattering (speckles) as internal reference. MATERIALS AND
METHODS This prospective, institutional review board-approved, Health Insurance Portability and Ac-
countability Act-compliant prospective comparison study was performed with prior written informed
consent from 20 women. Ten women with histological proven breast cancer and 10 with fibroadenoma
were measured. A conventional US system with a linear probe was used for SoS-US (SonixTouch; Ul-
trasonix, Richmond, British Columbia, Canada). Tissue speckle reflections served as a timing reference
for the US signals transmitted through the breasts. Relative phase inconsistencies were detected using
plane wave measurements from different angular directions, and SoS images with 0.5-mm resolution were
generated using a spatial domain reconstruction algorithm. The SoS of tumors were compared with the
breast density of a larger cohort of 106 healthy women. RESULTS Breast lesions show focal increments
ΔSoS (meters per second) with respect to the tissue background. Peak ΔSoS values were evaluated.
Breast carcinoma showed significantly higher ΔSoS than fibroadenomas ([INCREMENT]SoS > 41.64
m/s: sensitivity, 90%; specificity, 80%; area under curve, 0.910) and healthy breast tissue of different
densities (area under curve, 0.938; sensitivity, 90%; specificity, 96.5%). The lesion localization in SoS-
US images was consistent with B-mode imaging and repeated SoS-US measurements were reproducible.
CONCLUSIONS Using SoS-US, based on conventional US and tissue speckles as timing reference, breast
carcinoma showed significantly higher SoS values than fibroadenoma and healthy breast tissue of different
densities. The SoS presents a promising technique for differentiating solid breast lesions.
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Purpose: The aim of this study was to differentiate malignant and benign solid
breast lesions with a novel ultrasound (US) technique, which measures speed
of sound (SoS) using standard US transducers and intrinsic tissue reflections
and scattering (speckles) as internal reference.
Materials and Methods: This prospective, institutional review board–approved,
Health Insurance Portability and Accountability Act-compliant prospective compari-
son study was performed with prior written informed consent from 20 women. Ten
women with histological proven breast cancer and 10 with fibroadenoma were mea-
sured. A conventional US system with a linear probe was used for SoS-US
(SonixTouch; Ultrasonix, Richmond, British Columbia, Canada). Tissue speckle re-
flections served as a timing reference for the US signals transmitted through the
breasts. Relative phase inconsistencies were detected using planewavemeasurements
from different angular directions, and SoS images with 0.5-mm resolution were gen-
erated using a spatial domain reconstruction algorithm. The SoS of tumors were com-
pared with the breast density of a larger cohort of 106 healthy women.
Results: Breast lesions show focal incrementsΔSoS (meters per second) with re-
spect to the tissue background. Peak ΔSoS values were evaluated. Breast carci-
noma showed significantly higher ΔSoS than fibroadenomas (∆SoS > 41.64 m/s:
sensitivity, 90%; specificity, 80%; area under curve, 0.910) and healthy breast tissue
of different densities (area under curve, 0.938; sensitivity, 90%; specificity, 96.5%).
The lesion localization in SoS-US images was consistent with B-mode imaging and
repeated SoS-US measurements were reproducible.
Conclusions: Using SoS-US, based on conventional US and tissue speckles as
timing reference, breast carcinoma showed significantly higher SoS values than
fibroadenoma and healthy breast tissue of different densities. The SoS presents
a promising technique for differentiating solid breast lesions.
Key Words: differentiation, detection, breast, density, cancer, fibroadenoma,
speed of sound, tumor, breast lesion, ultrasound
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W ith an estimate of approximately new 1.7 million cases per yearworldwide, breast cancer is the most common malignant tumor
and the leading cause of cancer-related death in women worldwide.1
Fibroadenomas present the most common benign breast lesions.2Mam-
mography is the current criterion standard for breast cancer screening.
However, due to the inherent radiation exposure, reduced sensitivity in dense
breasts as well as the patient discomfort caused by tissue compression addi-
tional methods are needed. Supplemental ultrasound (US) imaging has been
shown to have the potential to detect small3 andmammographically ob-
scured4,5 tumors and to distinguish fibroadenomas from triple-negative
breast cancer.6 Elastography (strain and shear wave) increased accuracy
and specificity of US with respect to US alone (B-mode) or US with
Doppler imaging in the distinction of small, oval, or round triple-
negative breast cancer from fibroadenoma.7 For breast cancers, shear
wave elastography demonstrated a correlation with both histopathological
and mechanical tumor properties.8 However, a major limitation of both
US9 and elastography10 is the dependency on the examiners' experience
and few standardization. Currently, US differentiation of solid breast le-
sions is based on the qualitative analysis of tumor margins and geometry
(for instance, spiculation, boundary uniformity, ovality) of the lesions,
whereas the echogenicity of the lesion on its own does not provide enough
contrast for differentiation. In the case of elastography, quantitative bio-
markers (strain ratios, shear wave velocity) can be provided as surrogates
to stiffness.11,12 However, these measurements can be subject to con-
founders, such as dependency on tissue precompression and region of in-
terest, and special care must be taken to avoid or interpret artifacts.13
Moreover, in some cases, cancers do not appear as stiff lesions.14
Breast cancer imaging is currently a rapidly changing world with
a constant flux of new ideas for diagnostics and treatment15methods. A
variety of methods have been developed, which allow for objective tissue
quantification for both MRI16 and x-rays.17,18 Ultrasound imaging is not
foreign to this trend, with continuous advances based on elastography,19,20
contrast agents,21 optoacoustic imaging,22,23 and texture analysis,24 among
others. In recent years, an alternative US technology, US computed tomog-
raphy (USCT), has been developed for tissue quantification, and has shown
potential to both detect and differentiate breast lesions.25–27Current USCT
systems use a transmission US setup, in which the breasts are immersed in
awater bath, and dedicated ring transducers are used to transmit and receive
US pulses along multiple paths. Apart from conventional reflectivity im-
ages (B-mode), this allows imaging additional quantitative parameters of
longitudinal US waves, such as the speed of sound (SoS) and the acoustic
attenuation at multiple frequencies. These parameters have been shown to
be independent from stiffness surrogates provided by elastography, and
thus may contain additional information for tumorous tissue detection
and differentiation.25–29
Ultrasound computed tomography methods are dedicated sys-
tems for breast imaging. It would, however, be desirable to add quanti-
tative biomarkers also to standard US systems based on hand-held US
array probes. The SoS imaging would then be an additional functional-
ity of the USmachine, which, similar to Doppler or elastography, would
be overlaid to the B-mode images, and allow detection and quantifica-
tion of breast lesions. Some works have attempted to obtain average
SoS values in soft tissues from the deblurring of US images.30–32More
recently, several research works have attempted to obtain spatially re-
solved SoS images based on US probes and analysis of reflected US
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signals.32–34Two-dimensional (2D) SoS-US is a novel technique, which uses
a conventional US system tomeasure SoS in breast tissue (Fig. 1).34External
reflectors in combination with hand-held US probes have been used to
measure SoS (external reflector-based method).35,36 Sanabria et al.34 have
shown the potential of tissue reflections and scattering (speckles) to
serve as internal reflector and timing references, which leads to even
easier measurement operability for SoS imaging by hand-held probes.
The goal of this study was to investigate the feasibility of
SoS-US to differentiate breast cancer from fibroadenoma and healthy
breast tissue using conventional US probes and the SoS imaging
method using tissue reflections (speckles-based SoS method).
MATERIALS AND METHODS
Study Design
This prospective, single-institution study was approved by the
institutional review board and local ethics committee. Informed written
consent was obtained from all women. Twenty women presenting with
sonographic solid breast lesions that required biopsy were examined at
the University Hospital of Zurich between September 2016 and August
2017. B-mode and 2D SoS of each lesion were performed. The specimen
of the biopsied lesion sample was sent to the Institute of Pathology for
histopathological assessment. Inclusion criterion was a pathologic diag-
nosis of invasive lobular carcinoma (ILC), invasive carcinoma (IDC) or
fibroadenoma. Twenty women agreed to participate in the study. No se-
lection was made with regard to the patient's age or breast density. The
median age was 42 years for the fibroadenoma patients (ranging from
17–79 years) and 79 years for the carcinoma patients (ranging from
57–89 years). The patient characteristics are listed in Tables 1 and 2.
The SoS of the tumors (n = 20) of this study were compared with
the SoS of breast tissue segments (retromamillary, inner, and outer) of
106 healthy women.35 Speckles-based 2D SoS-US images as well as
mammographic breast density categories (A, almost entirely fatty; B,
scattered areas of fibroglandular density; C, heterogeneously dense;
and D, extremely dense) according to the American College of Radiol-
ogy (ACR) Breast Imaging Reporting and Data System (BIRADS) fifth
edition37 were acquired in 318 tissue segments.
Speed of Sound Ultrasound
A commercially available US system (SonixTouch; Ultrasonix,
Richmond, British Columbia, Canada) with a 9-MHz linear US array
(L14/5–38) was used for US imaging. The US probe has 128 elements,
with a pitch of 0.3 mm between elements, an element elevation of 7 mm
and a total aperture of 38 mm. B-mode images were used for lesion navi-
gation and acquired from the clinical interface of the device, which incor-
porates standard beam-forming and scan conversion filters. For SoS
imaging, a multichannel data acquisition board (SonixDAQ, Ultrasonix)
was used to simultaneously collect prebeamformed data from all probe el-
ementswith 40-MHz sampling rate and 12 bits per sample. Then, raw data,
also called multistatic data or full-matrix data, were acquired by sequen-
tially transmitting a pulse with an aperture of 1 element and recording the
received echoes with all other elements. In total, 128  128 = 16′384
prebeamformed lines were recorded (about 100MB/measurement). A cus-
tom add-on software and an interface developed for this purposewere used
for data acquisition and SoS image evaluation.
Principle From SoS-US Image Reconstruction
The generation of SoS-US images out of tissue reflections has been
described and validated with numerical simulations by Sanabria et al.34
FIGURE 1. Speed of sound (SoS) image reconstruction steps34 for an invasive ductal carcinoma (IDC) lesion with speckles-based SoS method. A,
Ultrasound plane wave images of the lesion are generated from multiple directions θ. B, Apparent tissue displacements are measured with a speckle
tracking algorithm, only measurements over a correlation threshold are preserved. C, A spatial domain reconstruction algorithm provides an SoS image.
The lesion mask annotated from B-mode is used for quantitative evaluation of the SoS increment △SoS in the lesion (m/s).
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The main steps are summarized in Figure 1. When US waves are incident
on tissuemicrostructure, diffuse scattering occurs, which is responsible for
the gray shade texture observed in US images (speckle). The reflecting tar-
gets (so-called scatterers) are smaller than the wavelength, leading to uni-
form scattering in all directions. Hence, the tissue texture in the images
does not change significantly with the angle of incidence of the wave.38,39
In breast tissue, scattering is mainly produced by fat and glandular cells,
which show isoechoic appearance; thin, echogenic Cooper ligaments
structures; and intensely echogenic stromal fibrous tissue.40
By coregistering US images acquired from different angular di-
rections, apparent tissue displacements can be measured, which are
caused by time shifts of the US wave travelling through regions with
different SoS properties. A spatial domain reconstruction algorithm34
is then used to reconstruct an SoS image from the tissue displacements.
In analogy to compression sensing algorithms,41 spatial domain recon-
struction uses regularization to achieve reconstructions, which are ro-
bust to missing/noisy displacement data and enhance delineation of
focal lesion geometries. The data acquisition and reconstruction set-
tings are the same as in the experiments shown by Sanabria et al.34with
the same regularization used for all clinical reconstructions. The SoS
images are reconstructed with a pixel size of 0.5 mm in the same coor-
dinate frame as the B-mode images. Displacement measures with low
correlation coefficient (r <0.3) are excluded. The algorithm evaluates
absolute SoS variations from the average background breast SoS value,
referred as ∆SoS, as a quantitative imaging biomarker. ∆SoS is
expressed in meters per second (m/s).
The maximum value of the resulting SoS images is evaluated
and used for classification between healthy tissue, fibroadenoma, and
carcinoma tissue. For fibroadenoma and carcinoma differentiation, ad-
ditionally, closed loop lesion masks were annotated in the B-mode im-
ages by an experienced sonographer, and the maximum SoS value was
evaluated within these masks. Peritumoral tissue region was also con-
sidered by dilating the annotated masks by a defined radius and then
reevaluating SoS values within the dilated masked regions.
SoS-US Breast Examination
Three experienced (25, 15, and 15 years of experience, respec-
tively) breast sonographers performed the examinations. There were
no differences between them in doing the examination. All 3 sonogra-
phers used a standardized protocol measuring SoS in the plane showing
the greatest diameter of the tumor.
First, a conventional US examination (B-mode) is carried out in
the clinical mode of the USmachine, and the US probe is navigated to a
TABLE 2. Clinical Characteristics of n = 10 Patients with Fibroadenoma Lesions
FA1 FA2 FA3 FA4 FA5 FA6 FA7 FA8 FA9 FA10
Breast density NA NA NA NA NA NA C A C B
Bra cup A B B B B NA NA NA B B
Age 17.0 22.0 30.0 25.0 46.0 38.0 55.0 79.0 78.0 51.0
Menopausal status Pre Pre Pre Pre Pre Pre Post Post Post Peri
BMI 21.8 20.8 25.2 19.4 23.0 NA NA NA NA 28.4
Histology FA FA FA FA FA FA FA FA FA FA
Location lesion LI LI LM LM LO LM LM RM LO LO
Horizontal diameter, mm 9.0 8.0 25.4 5.1 4.1 18.1 10.5 22.8 8.6 4.7
Vertical diameter, mm 10.8 6.3 13.8 5.4 3.8 3.4 11.6 5.4 4.2 3.4
∆SoS, m/s 7.7 7.4 15.7 79.1 13.7 7.6 41.6 4.9 43.2 13.8
∆SoS classification Benign Benign Benign Malignant Benign Benign Benign Benign Malignant Benign
NA indicates not available; BMI, bodymass index; RI, right inner; RM, right retromamillary; RO, right outer; LI, left inner; LM, left retromamillary; LO, left outer; FA,
fibroadenoma; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma.
TABLE 1. Clinical Characteristics of n = 20 Patients with Carcinoma Lesions
CA1 CA2 CA3 CA4 CA5 CA6 CA7 CA8 CA9 CA10
Breast density B A C NA B B A A C B
Bra cup A B B B B NA NA NA B B
Age 80 66 69 88 68 89 79 79 82 57
Menopausal status Post Post Post Pre Post Post Post Post Post Post
BMI NA 22.0 24.6 23.9 NA NA NA NA 28.7 NA
Histology IDC IDC IDC IDC IDC IDC IDC IDC ILC ILC
Location lesion LO LM RM LO LM RO LO RO LM RO
Horizontal diameter, mm 7.2 9.2 6.1 11.2 27.3 15.7 11.1 12.9 18.9 8.8
Vertical diameter, mm 4.5 9.7 5.2 8.9 22.2 24.4 12.5 20.6 14.3 10.1
∆SoS, m/s 47.7 59.7 42.7 14.2 93.1 106.7 113.6 79.2 118.0 73.3
∆SoS classification Malignant Malignant Malignant Benign Malignant Malignant Malignant Malignant Malignant Malignant
NA indicates not available; BMI, body mass index; RI, right inner; RM, right retromamillary; RO, right outer; LI, left inner; LM, left retromamillary; LO, left outer;
IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma.
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2D plane containing the lesion of interest. The size of the lesion is
assessed in 3 planes, and the planewith the largest lesion diameter is se-
lected. ThenUSmultistatic data are acquired at the lesion planewith the
same US probe. The data acquisition is performed in less than 0.1 sec-
ond (frame rate >10 Hz). The present US system has a hardware
switching delay between clinical mode and multistatic data acquisition
mode of approximately 30 seconds. During this time, the sonographer
must hold the probewith respect to the patient to avoid losing the region
of interest. The SoS images are then automatically generated and
displayed as a color overlay to B-mode images, with an adjacent quan-
titative scale of ∆SoS (m/s) (Figs. 2, 3). The bottom and lateral edges of
the ∆SoS images are subject to speckle decorrelation and beamforming
artifacts and were excluded from the evaluation (radius, 8.4 mm). For
differential diagnosis, we used both the maximum ∆SoS value within
the reconstructed SoS image (Fig. 4) and the maximum ∆SoS value
within a region of interest around the lesion as visible in the B-mode
image (Figs. 5,6).
Statistical Analysis
Statistical analysis was performed using Matlab (2014a, The
MathWorks Inc, Natick, MA). Analysis of variance (ANOVA) was
used for comparison of healthy breast segments, carcinomas, and
fibroadenomas. A P value less than 0.05 was considered to indicate
statistical significance. Receiver operating characteristic (ROC)
analysis was performed with MedCalc 18.2.1 (2018, Ostend,
Belgium) to evaluate area under curve (AUC). For illustration,
MedCalc also automatically calculates sensitivity and specificity
based on the optimum cutoff point for the test sample size, which
FIGURE 2. B-mode (first and third rows) and speed of sound images (second and fourth rows) for carcinoma lesions. There was one false-negative (CA4),
which is marked with an asterisk, corresponding to an invasive carcinoma (IDC) with 11.2 mm diameter in the retromamiliary segment of a heterogeneously
dense (ACR type C) breast.
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is calculated with prevalence of 0.5 for both groups and same cost
of false- and true-positive and negative decisions.42
RESULTS
Twenty (100%) of 20measurementswere successful. Fibroadenomas
had diameters between 4.1 and 25.4mm (median, 8.8 mm), whereas the
carcinomas were between 6.1 and 27.3 mm (median, 11.2 mm).
B-mode and SoS images, together with B-mode/SoS overlays are
shown in Figure 2 for carcinoma and Figure 3 for fibroadenoma. Based
on the evaluation of the full reconstructed SoS images, there was a signif-
icant difference between fibroadenomaand carcinoma (P<0.001; Fig. 4A).
After ROC analysis, the criterion ∆SoS greater than 41.64 m/s provided
sensitivity of 90%, specificity of 80%, and AUC of 0.910 (Fig. 4B).
Nine of 10 carcinomas are characterized by higher SoS values,
which show red spots in the images. There was 1 false-negative
(CA4), corresponding to an IDC with 11.2 mm diameter in the
retromamiliary segment of a heterogeneously dense (ACR type
C) breast (Table 1). Eight of 10 fibroadenomas were correctly classi-
fied. There were 2 false-positives FA4 and FA9. FA4 shows high
∆SoS values at the left image edge, where poor acoustic coupling
is also observed. FA9 shows ∆SoS = 43.2 m/s, which is very close
to the cutoff value (Table 2). We did not observe significant differ-
ences between ∆SoS for carcinoma in breasts of different densities.
Incidentally, the largest ∆SoS = 118.0 m/s was observed for patient
CA9, which has a dense breast (ACR type C). The comparison of
∆SoS between IDC (n = 8) and ILC (n = 2) did not show a significant
difference (t test P = 0.367).
Second, the SoS was evaluated based on the annotated lesion re-
gions in the B-mode images. Seven of 10 lesions show a ∆SoS centroid
within the B-mode lesion annotation region (yellow dotted line in
FIGURE 3. B-mode (first and third rows) and speed of sound images (second and fourth rows) for fibroadenoma lesions. There were 2 false-positives FA4
and FA9, which are marked with an asterisk. FA4 shows high △SoS values at the left image edge, where poor acoustic coupling is also observed. FA9
shows △SoS = 43.2 m/s, which is very close to the cutoff value.
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Fig. 6). CA1 has a centroid within the peritumorial region and CA3 out-
side the annotated lesion region. Inclusion of a peritumoral region of
6 mm around the annotated lesion as part of the masked region of inter-
est (blue dashed line in Fig. 6) provided best AUC of 0.930 for
fibroadenoma/carcinoma differentiation (Fig. 5). With this evaluation
mask, the criterion ∆SoS of 43.16 m/s provided sensitivity of 80%
and specificity of 100%. Restricting ∆SoS evaluation to the masked re-
gions also eliminated the false-positive FA4, which occurs outside the
lesion's actual position, and FA9, because a higher cutoff value could
be applied. On the other hand, an additional false-negative CA3 was ob-
served, because the observed ∆SoS increased did not match the masked
region. Repeated measurements were available for 3 lesions (CA6,
CA8, FA2). For each case, the lesion was relocated in B-mode and
reassessed with SoS. The peak ∆SoS values in the repeated measure-
ments (106.7m/s for CA6, 78.8m/s for CA8, and 17.8m/s for FA2) were
reproducible with respect to the first measurements in Tables 1 and 2,
with (1 m/s, 0.4 m/s, and 10.5 m/s) ∆SoS uncertainties, respectively.
Of the 318 available SoS measurements in healthy women,
18/318 (6%) were excluded due to lack of acoustic coupling and 42/318
(13%) were excluded due to low-quality tissue displacement maps (only
<60% of tissue displacement pixels available). From the remaining 258
segments, 61/258 (24%) were classified as ACR type A, 105/258 (41%)
as type B, 62/258 (24%) as type C, and 30/258 (12%) as type D. We
found a significant SoS difference between carcinoma lesions and each
of the healthy tissue segment types (P < 0.001 for both ACR types A, B,
C, and D; Fig. 7A). After ROC analysis, the criterion ∆SoS greater than
41.17 m/s provided sensitivity of 90%, specificity of 96.5%, and AUC
of 0.938 (Fig. 7B). The ∆SoS comparison of fibroadenomas with each
of the 4 differently dense healthy tissue was not significant. No
significant ∆SoS difference was found when comparing the healthy
tissues of different density categories among each other.
DISCUSSION
This study shows that breast cancer can be differentiated from
fibroadenoma and healthy tissue of any density category using tissue re-
flections. The lesion localization in SoS-US images was consistent with
B-mode imaging and repeated SoS-US measurements were reproduc-
ible. The technology works on standard US hardware, with a custom
add-on software and a user interface developed for this purpose. The
method can be applied to detect breasts with cancerous tumors and to
differentiate between different lesion types.
SoS-US measurements have been performed in the past decade
in several centers worldwide with special 3-dimensional (3D) US to-
mography machines. For a commercial 3D-USCT SoS measurement
system, Duric et al25 showed intermediate and high SoS, as well as at-
tenuation for carcinoma (n = 38), while fibroadenoma (n = 31) exhib-
ited lower values (specificity, 83.9%; sensitivity, 100%). The cutoff
value was an SoS increase by 2.42%, which is equivalent to ∆SoS
greater than 36 m/s, in good agreement with the cutoff values and
FIGURE 5. ANOVA (A) and ROC (B) plots for differentiation of fibroadenoma (FA) and carcinoma (CA). The evaluation is restricted to the lesion regions
annotated in the B-mode by the sonographer augmented by a peritumorial region of 6 mm (blue dashed line in Fig. 6).
FIGURE 4. ANOVA (A) and ROC (B) plots for differentiation of fibroadenoma (FA) and carcinoma (CA). The evaluation is based on the fully reconstructed
SoS image.
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specificity observed in our pilot study. Using a method fusing USCT
images and x-ray mammograms, Hopp et al43 presented a technique
promising for the differentiation of tumors and healthy tissue. Using a
system combining transmission and reflection,28 André et al were able
to differentiate fibroadenoma (n = 11) from carcinoma (n = 5) with a
specificity of 81.8% and sensitivity of 100%. Using a similar system,
Iuanow et al44 demonstrated differentiation of cysts from solid lesions.
Three-dimensional multimodal US tomography combines multiple
acoustic parameters into a composite index and has shown the capacity
to distinguish malignant lesions from healthy tissue as well as from be-
nign lesions and to detect small breast lesions.26,27,29 From the available
literature evidence, it cannot be concluded that ∆SoS in tumors is
different for breast of different densities.26,43,45–47 The SoS increase
in tumors has been referred to microstructural distortion and densifica-
tion of healthy tissues,26,48 in which case a significant ∆SoS increase
can be hypothesized regardless of the density of the breast. To the best
of our knowledge, significant differences between ∆SoS in IDC and
ILC have not been reported in the literature, and more sophisticated
multiparametric biomarkers may be necessary to differentiate between
different breast cancer subtypes.26,43,48,49
Compared with 3D-US tomography, our novel 2D technique has
several advantages. The technique can be performed with standard US
hardware in any body position. The method does not require a large,
degassed, hygienic water bath, prone position, or dedicated table. The
FIGURE 6. Carcinoma (CA) localization in SoS images (second and fourth rows) with respect to the lesion regions annotated in the B-mode by the
sonographer (first and third rows). Sonographer annotations (yellow dotted line) were dilated with a radius of 6mm to capture the peritumorial region
(blue dashed line). The centroid position of the △SoS tumor images (whitemarker) and their bounding boxwith respect to a 50% threshold of the 42m/s
cutoff value (solid white line) are automatically extracted from the SoS images and shown as a reference. Seven of 10 lesions show a centroid within the
B-mode lesion annotation region. CA1 has a centroid within the peritumorial region and CA3 outside the marked lesion region.
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corresponding equipment cost is low, and the necessary clinical space is
small. The measurement time is reduced. This pilot study showed that
SoS-US measurements were easily and rapidly performed and well tol-
erated. There was no need for a contrast agent or breast compression.
The method described by Sanabria et al.34 and studied in this ar-
ticle for breast cancer could be used for differentiating solid breast le-
sions. Further studies are needed to assess the benefit in the
differentiation between BI-RADS 3 and 4 lesions. This could poten-
tially reduce the number of false-positive biopsies as well as the number
of falsely down-staged lesions. Similarly to what has already been
shown for US by Sannachi et al50 and for SoS US by Lupinacci et al,51
SoS-US could potentially be used as a fast and easy tool to predict the
tumor response to chemotherapy. The current resolution is too low to
make a conclusive statement on inner lesion structure. We are currently
improving the signal-to-noise ratio of our prototype to increase the cor-
relation in tissue displacement measures. A combination with diffrac-
tion tomography as reported by Huthwaite et al52 and Simonetti
et al53 or full waveform inversion algorithms as presented by Wang
et al54 could present additional ways to improve the resolution and en-
able an improved insight into inner lesion characteristics.55
Our current installment contains some limitations, such as nonsi-
multaneous acquisitions of the B-mode image and SoS, which de-
creases the accuracy of the mask. We also observed bad coupling in
the borderline areas, which was associated with high SoS values. The
lack of whole breast coverage presents a further limitation. These limi-
tations are of technical nature and can be improvedwith further refining
of the data acquisition platform to achieve real-time visualization of
SoS images in parallel to the B-mode, as it is nowadays possible with
other elastography modalities.10,11,22,56,57 There is potential for techno-
logical improvement in the lesion geometric delineation, for instance
through improved image reconstruction and displacement tracking
strategies, which would be necessary to analyze intratumor heterogene-
ity. Accordingly, in this current study, we considered the maximum
∆SoS values as a biomarker, which already shows the feasibility for
cancer diagnosis. The proposed algorithm also depends on the availabil-
ity of rich tissue texture to track phase displacements from different an-
gular directions. Similarly to preceding 3D-USCT SoS studies, some
overlap between SoS of fibroadenoma and carcinomawas found, which
may be reduced with composite biomarkers (multiparametric imaging).
Given the small sample size, most of the included breast cancers were
incidentally in an elderly population. Although no significant difference
in ∆SoS was found between cancerous lesions in dense (ACR type
C) and nondense breasts (ACR types A and B), a larger study is neces-
sary to cover patients in a wider age range and lesions in breasts of all
density categories to validate the cutoff point of the ROC. The optimum
∆SoS cutoff point determined in this study should also be applied pro-
spectively to an independent sample.
In conclusion, using SoS-US based on conventional US hard-
ware and internal tissue reflections, breast carcinoma showed
significant higher SoS values than fibroadenoma and healthy breast tis-
sue of different densities.
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